ProPhase Labs PRPH will release its quarterly earnings report on Monday, 2025-03-31. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate ProPhase Labs to report an earnings per share (EPS) of $-0.24.
The market awaits ProPhase Labs's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
During the last quarter, the company reported an EPS missed by $0.39, leading to a 2.42% drop in the share price on the subsequent day.
Here's a look at ProPhase Labs's past performance and the resulting price change:
Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
---|---|---|---|---|
EPS Estimate | 0.04 | -0.24 | -0.28 | -0.26 |
EPS Actual | -0.35 | -0.33 | -0.07 | -0.51 |
Price Change % | -2.0% | -10.0% | 3.0% | 4.0% |
Performance of ProPhase Labs Shares
Shares of ProPhase Labs were trading at $0.46 as of March 27. Over the last 52-week period, shares are down 93.76%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for ProPhase Labs visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.